| Dr Chatur J Babaria, MD | |
|
22707 S Ellsworth Rd, Ste H-103, Queen Creek, AZ 85142-6131 | |
| (480) 677-3494 | |
| (480) 677-4319 |
| Full Name | Dr Chatur J Babaria |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 38 Years |
| Location | 22707 S Ellsworth Rd, Queen Creek, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568514404 | NPI | - | NPPES |
| 895104 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 32966 (Arizona) | Primary |
| Entity Name | Chatur J Babaria Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659559417 PECOS PAC ID: 5890855258 Enrollment ID: O20081117000028 |
News Archive
Following an innovative, years long advocacy campaign spearheaded by AIDS Healthcare Foundation (AHF) that targeted Merck and Co. Pharmaceuticals over the pricing of its AIDS drug Isentress—one of the most expensive first line AIDS therapies on the US market today—officials from AHF lauded Merck today for significant concessions that the drug giant is putting in place on its pricing and rebate policies for the nation's AIDS Drug Assistance Programs (ADAP), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need.
While mainstream news coverage is still a primary source of information for the latest in policy debates and the health care marketplace, online blogs have become a significant part of the media landscape, often presenting new perspectives on policy issues and drawing attention to under-reported topics.
The Basic Health program has played an important role in extending the safety net to provide coverage to many low-income people who can't afford to purchase coverage on their own and don't qualify for Medicaid. It's much easier to retain an infrastructure than to build a new one from scratch. Simply put, leaving people without health insurance lengthens the recession and imposes costs on us all.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema secondary to Retinal Vein Occlusion (RVO).
Two groundbreaking studies at the UC Davis MIND Institute provide clues about possible types of autism linked to brain structure, including size and white matter growth.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chatur J Babaria, MD 22707 S Ellsworth Rd, Ste H-103, Queen Creek, AZ 85142-6131 Ph: (480) 677-3494 | Dr Chatur J Babaria, MD 22707 S Ellsworth Rd, Ste H-103, Queen Creek, AZ 85142-6131 Ph: (480) 677-3494 |
News Archive
Following an innovative, years long advocacy campaign spearheaded by AIDS Healthcare Foundation (AHF) that targeted Merck and Co. Pharmaceuticals over the pricing of its AIDS drug Isentress—one of the most expensive first line AIDS therapies on the US market today—officials from AHF lauded Merck today for significant concessions that the drug giant is putting in place on its pricing and rebate policies for the nation's AIDS Drug Assistance Programs (ADAP), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need.
While mainstream news coverage is still a primary source of information for the latest in policy debates and the health care marketplace, online blogs have become a significant part of the media landscape, often presenting new perspectives on policy issues and drawing attention to under-reported topics.
The Basic Health program has played an important role in extending the safety net to provide coverage to many low-income people who can't afford to purchase coverage on their own and don't qualify for Medicaid. It's much easier to retain an infrastructure than to build a new one from scratch. Simply put, leaving people without health insurance lengthens the recession and imposes costs on us all.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema secondary to Retinal Vein Occlusion (RVO).
Two groundbreaking studies at the UC Davis MIND Institute provide clues about possible types of autism linked to brain structure, including size and white matter growth.
› Verified 6 days ago
Dr. Kaleigh Suhs, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 37100n. Gantzel Rd., Ste. 107, Queen Creek, AZ 85140 Phone: 480-394-4480 Fax: 602-805-2828 | |
Judd A Shafer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7205 S Power Rd Ste 100, Queen Creek, AZ 85142 Phone: 480-728-6000 Fax: 480-728-6900 | |
Stephanie Deborah Kotsur, NP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21321 E Ocotillo Rd Ste 133, Queen Creek, AZ 85142 Phone: 480-987-5525 Fax: 480-987-5115 | |
Daniel B Hoag, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 20715 E Ocotillo Rd, Suite 102, Queen Creek, AZ 85142 Phone: 480-987-0987 | |
Dr. Dorian Lorrae Richardson, ND Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 36460 N Encanterra Dr, Queen Creek, AZ 85140 Phone: 520-505-1944 | |
Tracey Lynn Cooper, FNP-BC Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 19724 E Emperor Blvd, Queen Creek, AZ 85142 Phone: 520-349-8482 | |
Adelaide Amini, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21772 S Ellsworth Loop Rd, Queen Creek, AZ 85142 Phone: 480-512-3700 |